Prof. Dr. Christoph Arnoldner is an Expert in the HEARRING Network. His contact information:
Phone: +43 1 40400 33760
Email: christoph.arnoldner@meduniwien.ac.at

Colleagues

HEARRING CENTER

Medical University of Vienna
Universitätsklinik für Hals-, Nasen- und Ohrenkrankheiten

Spitalgasse 23, 1090 Vienna, Austria
Phone: +43 1 404 00 3305
Web: www.meduniwien.ac.at

Abstracts

Residual Hearing Preservation Using a Non-Mastoidectomy Technique for Cochlear Implantation

Authors: Arnoldner C, Riss D, Wagenblast J, Hamzavi JS, Jappel A, Gstoettner W, Baumgartner WD
Journal: Wien Klin Wochenschr. 2011 Oct;123(19-20):599-602. IF=0,836

Envelope versus fine structure speech coding strategy - A crossover study

Authors: Riss D, Hamzavi JS, Selberherr A, KaiderA, Blineder M, Starlinger V, Gstoettner W, Arnoldner C
Journal: Otol Neurotol. 2011 Sep;32(7):1094-101. IF=1,953

Endolymphatic sac tumor and angiomatous lesions of the nasal and pharyngeal mucosa as a first manifestation of von Hippel-Lindau disease.

Authors: Honeder C, Gstoettner W, Matula C, Czerny C, Gruber A, Ramsebner, Arnoldner C.
Journal: Laryngoscope. 2012 Oct;122(10):2300-3. IF=2,272

Facial nerve prognostication in vestibular schwannoma surgery: The concept of percent maximum and its predictability.

Authors: Arnoldner C, Mick P, Pirouzmand F, Houlden D, Lin VY, Nedzelski JM, Chen JM.
Journal: Laryngoscope. 2013;123(10):2533-8. IF=2,272

Ten-year health-related quality of life in cochlear implant recipients: Prospective SF-36 Data With SF-6D Conversion

Authors: Arnoldner C, Lin VY, Honeder C, Shipp D, Nedzelski J, Chen J.
Journal: Laryngoscope. 2013 Sep 23 IF=2,272

Expanded selection criteria in adult cochlear implantation.

Authors: Arnoldner C, Lin VY.
Journal: Cochlear Implants Int. 2013 Nov;14 Suppl 4:S10-3.

Quality of Life in Cochlear Implantees: Comparing Utility Values obtained through SF-6D and HUI-3.

Authors: Arnoldner C, Lin VY, Bresler R, Kaider A, Kuthubutheen J, Shipp D, Chen JM.
Journal: Laryngoscope. 2014 Feb 18. IF=2,272

Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear.

Authors: Engleder E, Honeder C, Klobasa J, Wirth M, Arnoldner C, Gabor F.
Journal: Int J Pharm. 2014 Jun 2;471(1-2):297-302. IF=3,994

Sustained Release of Triamcinolone Acetonide from an Intratympanically Applied Hydrogel Designed for the Delivery of High Glucocorticoid Doses.

Authors: Honeder C, Engleder E, Schöpper H, Gabor F, Reznicek G, Wagenblast J, Gstoettner W, Arnoldner C.
Journal: Audiol Neurootol. 2014 Apr 2;19(3):193-202. IF=1,776

Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double-blind, randomized, placebo-controlled trial.

Authors: Riss D, Burian M, Wolf A, Kranebitter V, Kaider A, Arnoldner C.
Journal: Head Neck. 2014 Mar 4 IF=2,760

Determination of the glycosylation-pattern of the middle ear mucosa in guinea pigs.

Authors: Engleder E, Demmerer E, Wang X, Honeder C, Zhu C, Studenik C, Wirth M, Arnoldner C, Gabor F
Journal: Int J Pharm. 2015 Feb 24;484(1-2):124-130. IF=3,994

Effects of intraoperatively applied glucocorticoid hydrogels on residual hearing and foreign body reaction in a guinea pig model of cochlear implantation.

Authors: Honeder C, Landegger LD, Engleder E, Gabor F, Plasenzotti R, Plenk H, Kaider A, Hirtler L, Gstoettner W, Arnoldner C.
Journal: Acta Otolaryngol. 2015 Feb 26:1-7. IF=1,127

Evaluation of the selective glucocorticoid receptor agonist compound A for ototoxic effects.

Authors: Honeder C, Engleder E, Schöpper H, Krause M, Landegger LD, Plasenzotti R, Gabor F, Gstoettner W, Arnoldner C.
Journal: Laryngoscope. 2014 Nov 10. IF=2,272

Indication criteria and outcomes with the Bonebridge transcutaneous bone-conduction implant.

Authors: Riss D, Arnoldner C, Baumgartner WD, Blineder M, Flak S, Bachner A, Gstoettner W, Hamzavi JS.
Journal: Laryngoscope. 2014 Dec;124(12):2802-6. IF=2,272

FS4, FS4-p, and FSP: a 4-month crossover study of 3 fine structure sound-coding strategies.

Authors: Riss D, Hamzavi JS, Blineder M, Honeder C, Ehrenreich I, Kaider A, Baumgartner WD, Gstoettner W, Arnoldner C.
Journal: Ear Hear. 2014 Nov-Dec;35(6):e272-81. IF=2,517

Noise trauma and systemic application of the selective glucocorticoid receptor modulator compound A.

Authors: Landegger LD, Honeder C, Zhu C, Schöpper H, Engleder E, Gabor F, Gstoettner W, Arnoldner C.
Journal: J Negat Results Biomed. 2016 May 11;15(1):10

Dura and sinus compression with a transcutaneous bone conduction device - hearing outcomes and safety in 38 patients.

Authors: Vyskocil E, Riss D, Arnoldner C, Hamzavi JS, Liepins R, Kaider A, Honeder C, Fumicz J, Gstoettner W, Baumgartner WD.
Journal: Clin Otolaryngol. 2016. IF=2,627

Effects of Stimulation Rate With the FS4 and HDCIS Coding Strategies in Cochlear Implant Recipients.

Authors: Riss D, Hamzavi JS, Blineder M, Flak S, Baumgartner WD, Kaider A, Arnoldner C.
Journal: Otol Neurotol. 2016 Aug;37(7):882-8. IF=1,953

Effects of sustained release dexamethasone hydrogels in hearing preservation cochlear implantation.

Authors: Honeder C, Zhu C, Schöpper H, Gausterer JC, Walter M, Landegger LD, Saidov N, Riss D, Plasenzotti R, Gabor F, Arnoldner C.
Journal: Hear Res. 2016 Aug 9;341:43-49. IF=2,906

Masking release with changing fundamental frequency: Electric acoustic stimulation resembles normal hearing subjects.

Authors: Auinger AB, Riss D, Liepins R, Rader T, Keck T, Keintzel T, Kaider A, Baumgartner WD, Gstoettner W, Arnoldner C.
Journal: Hear Res. 2017 Jul;350:226-234. IF=2,906

Get in Contact

Please name the person you want to get in contact with.